zolpidem has been researched along with pentobarbital in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (23.53) | 18.2507 |
| 2000's | 9 (52.94) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Rowlett, JK; Woolverton, WL | 1 |
| Goldman, NH; Madakasira, S; Rowlett, JK; Rush, CR; Woolverton, WL | 1 |
| Greenfield, LJ; Macdonald, RL; Neelands, TR; Turner, RS; Zhang, J | 1 |
| Carter, RB; Edgar, DM; Fick, DB; Gee, KW; Hogenkamp, DJ; Lan, NC; Seidel, WF; Vanover, KE | 1 |
| Baker, RW; Rowlett, JK; Rush, CR | 1 |
| Kullmann, DM; Semyanov, A | 1 |
| Ator, NA | 1 |
| Alva, H; Blednov, YA; Harris, RA; Jung, S; Rosahl, T; Wallace, D; Whiting, PJ | 1 |
| Belknap, JK; Buck, KJ; Crabbe, JC; Kliethermes, CL; Metten, P | 1 |
| Hall, SD; Stanford, IM; Woodhall, GL; Yamawaki, N | 1 |
| Dunlap, S; Licata, SC; Lukas, SE; Penetar, DM | 1 |
| Buck, KJ; Kozell, LB; Milner, LC; Walter, NA; Wickman, K | 1 |
| Cho, S; Han, D; Jin, YH; Jin, Z; Kim, IH; Kim, S | 1 |
| Cho, NC; Cho, S; Kim, J; Lee, CJ; Pae, AN; Park, KD; Um, MY; Woo, J; Yang, H; Yoon, M | 1 |
1 review(s) available for zolpidem and pentobarbital
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for zolpidem and pentobarbital
| Article | Year |
|---|---|
Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
Topics: Adult; Caffeine; Discrimination Learning; Dose-Response Relationship, Drug; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Pentobarbital; Pyridines; Triazolam; Zolpidem | 1997 |
Discriminative-stimulus effects of zolpidem, triazolam, pentobarbital, and caffeine in zolpidem-trained humans.
Topics: Adult; Caffeine; Central Nervous System Stimulants; Cues; Discrimination Learning; Discrimination, Psychological; Female; Humans; Hypnotics and Sedatives; Male; Mental Recall; Pentobarbital; Psychomotor Performance; Pyridines; Surveys and Questionnaires; Triazolam; Zolpidem | 2000 |
14 other study(ies) available for zolpidem and pentobarbital
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: I. Comparison with triazolam in rhesus monkeys and rats.
Topics: Animals; Discrimination Learning; Dose-Response Relationship, Drug; Female; Hypnotics and Sedatives; Macaca mulatta; Male; Pentobarbital; Pyridines; Rats; Rats, Sprague-Dawley; Species Specificity; Triazolam; Zolpidem | 1997 |
GABAA receptor pharmacology and subtype mRNA expression in human neuronal NT2-N cells.
Topics: Anticonvulsants; Bicuculline; Carbolines; Convulsants; Diazepam; Diuretics; DNA Primers; Furosemide; GABA Modulators; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Humans; Hypnotics and Sedatives; Lanthanum; Neurons; Patch-Clamp Techniques; Pentobarbital; Phenobarbital; Picrotoxin; Polymerase Chain Reaction; Pregnanediones; Pregnenolone; Pyridines; Receptors, GABA-A; RNA, Messenger; Teratocarcinoma; Triazoles; Tumor Cells, Cultured; Zinc; Zolpidem | 1998 |
Response-rate suppression in operant paradigm as predictor of soporific potency in rats and identification of three novel sedative-hypnotic neuroactive steroids.
Topics: Animals; Conditioning, Operant; Depression, Chemical; Dose-Response Relationship, Drug; Electroencephalography; Hypnotics and Sedatives; Male; Pentobarbital; Postural Balance; Pregnanolone; Pregnenolone; Pyridines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Steroids; Triazolam; Zolpidem | 1999 |
Relative picrotoxin insensitivity distinguishes ionotropic GABA receptor-mediated IPSCs in hippocampal interneurons.
Topics: Animals; Bicuculline; Electrophysiology; Excitatory Postsynaptic Potentials; GABA Agonists; GABA Antagonists; GABA Modulators; gamma-Aminobutyric Acid; Guinea Pigs; Hippocampus; In Vitro Techniques; Interneurons; Iontophoresis; Membrane Potentials; Patch-Clamp Techniques; Pentobarbital; Picrotoxin; Pyramidal Cells; Pyridines; Receptors, GABA; Receptors, GABA-A; Zolpidem | 2002 |
Relation between discriminative and reinforcing effects of midazolam, pentobarbital, chlordiazepoxide, zolpidem, and imidazenil in baboons.
Topics: Animals; Benzodiazepines; Chlordiazepoxide; Discrimination, Psychological; Dose-Response Relationship, Drug; GABA Modulators; Generalization, Stimulus; Hypnotics and Sedatives; Imidazoles; Male; Midazolam; Papio; Pentobarbital; Pyridines; Reinforcement, Psychology; Self Administration; Zolpidem | 2002 |
Deletion of the alpha1 or beta2 subunit of GABAA receptors reduces actions of alcohol and other drugs.
Topics: Animals; Behavior, Animal; Brain; Central Nervous System Depressants; Chlorides; Ethanol; Etomidate; Female; Flurazepam; GABA Agonists; GABA Modulators; Gene Deletion; Hypnotics and Sedatives; Isoxazoles; Male; Mice; Mice, Knockout; Pentobarbital; Postural Balance; Pyridines; Receptors, GABA; Receptors, GABA-A; Sex Characteristics; Sleep; Time Factors; Zolpidem | 2003 |
Selection for pentobarbital withdrawal severity: correlated differences in withdrawal from other sedative drugs.
Topics: Analysis of Variance; Animals; Anticonvulsants; Behavior, Animal; Central Nervous System Depressants; Diazepam; Drinking Behavior; Ethanol; Female; Hypnotics and Sedatives; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Pentobarbital; Pyridines; Seizures; Selection, Genetic; Species Specificity; Substance Withdrawal Syndrome; Time Factors; Zolpidem | 2004 |
Pharmacologically induced and stimulus evoked rhythmic neuronal oscillatory activity in the primary motor cortex in vitro.
Topics: Animals; Beta Rhythm; Carbachol; Electric Stimulation; Electroencephalography; Excitatory Amino Acid Agonists; Extracellular Space; Fourier Analysis; GABA Agonists; GABA Antagonists; GABA Modulators; In Vitro Techniques; Kainic Acid; Male; Motor Cortex; Muscarinic Agonists; Neurons; Pentobarbital; Picrotoxin; Pyridines; Rats; Rats, Wistar; Receptors, GABA-A; Zolpidem | 2008 |
A therapeutic dose of zolpidem has limited abuse-like effects in drug-naïve females: a pilot study.
Topics: Adult; Antipsychotic Agents; Blood Pressure; Chlorpromazine; Female; Heart Rate; Humans; Hypnotics and Sedatives; Pentobarbital; Pilot Projects; Pyridines; Skin Temperature; Substance-Related Disorders; Young Adult; Zolpidem | 2008 |
Mapping a barbiturate withdrawal locus to a 0.44 Mb interval and analysis of a novel null mutant identify a role for Kcnj9 (GIRK3) in withdrawal from pentobarbital, zolpidem, and ethanol.
Topics: Animals; Area Under Curve; Behavior, Animal; Brain; Chromosome Mapping; Chromosomes, Human, Pair 1; Disease Models, Animal; DNA Mutational Analysis; Ethanol; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Gene Expression Regulation; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Knockout; Pentobarbital; Polymorphism, Single Nucleotide; Pyridines; Quantitative Trait Loci; Substance Withdrawal Syndrome; Zolpidem | 2009 |
Potentiating effect of glabridin on GABAA receptor-mediated responses in dorsal raphe neurons.
Topics: Animals; Anti-Anxiety Agents; Brain; Diazepam; Dose-Response Relationship, Drug; Flumazenil; GABA Agents; gamma-Aminobutyric Acid; Glycyrrhiza; Hypnotics and Sedatives; Isoflavones; Neurons; Pentobarbital; Phenols; Plant Extracts; Plant Roots; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Zolpidem | 2013 |
α-Pinene, a Major Constituent of Pine Tree Oils, Enhances Non-Rapid Eye Movement Sleep in Mice through GABAA-benzodiazepine Receptors.
Topics: Animals; Benzodiazepines; Bicyclic Monoterpenes; Binding Sites; Eye Movements; Flumazenil; Inhibitory Postsynaptic Potentials; Male; Mice, Inbred C57BL; Mice, Inbred ICR; Models, Molecular; Monoterpenes; Pentobarbital; Pinus; Plant Oils; Pyridines; Receptors, GABA-A; Sleep; Sleep, REM; Time Factors; Wakefulness; Zolpidem | 2016 |